Trump announces new drugmaker deals to lower drug costs, boost US investment

President Donald Trump introduced Friday that his administration has signed new agreements with among the world’s largest drug producers aimed toward decreasing the price of pharmaceuticals for People.

From the Roosevelt Room, Trump revealed that 9 further drugmakers have agreed to the administration’s most favored nation pricing initiative, bringing the full to 14 of the world’s 17 largest main corporations.

The settlement reached with the 9 corporations additionally consists of $150 billion in mixed new funding commitments in home pharmaceutical manufacturing, analysis and growth.

Friday’s announcement heralded offers with Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi – marking a profitable settlement between the producers and the Trump administration.

FOX NEWS POLL: VOTERS ARE ALARM ABOUT HEALTHCARE COSTS

U.S. President Donald Trump proclaims a cope with Pfizer to decrease Medicaid drug costs within the Oval Workplace of the White Home on September 30, 2025 in Washington, DC. (Win McNamee/Getty Pictures/Getty Pictures)

In July, Trump wrote letters to the leaders of the 17 largest drugmakers in search of a deal to maintain drug prices for these enrolled within the authorities’s Medicaid well being program beneath these in different high-income nations.

A number of of the present signatories have additionally agreed to donate energetic pharmaceutical components to America’s Strategic Energetic Pharmaceutical Components Reserve (SAPIR SAPIR) to help within the nation’s catastrophe response to potential pandemics, pure disasters or nationwide safety emergencies.

Beforehand, Pfizer, AstraZeneca and Serrano, Novo Nordisk and Lilly had struck offers with the Trump administration to maintain drug costs manageable for low-income People.

TRUMP’S QUEST TO LOWER DRUG PRICES IS ONGOING. BUT WILL HE BE ABLE TO DO IT?

The brand of Swiss drugmaker Novartis is seen on the firm’s new cell and gene remedy manufacturing facility in Stein, Switzerland, November 28, 2019. (REUTERS/Arnd Wiegmann/File Picture / Reuters)

Trump has routinely made prescription drug prices a cornerstone of his administration’s efforts, usually specializing in the disparity between costs within the U.S. and different rich nations, with analysts noting that Medicaid — which accounts for 10% of the nation’s drug spending — already advantages from important rebates from producers. according to Reuters.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Trump additionally introduced the federal government’s new web site, TrumpRX.govwill launch early subsequent 12 months in an effort to decrease prescription drug costs for People. A message on the location at the moment reads: “Coming quickly. January 2026.”